A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis

Summary

The purpose of this study is to determine whether tanezumab is effective and safe in the treatment of pain associated with endometriosis.

Timeline

Start

2008-12-18

Primary completion

2010-01-27

Completion

2010-04-05

Outcome

Missed primary endpoint

Stopped (Enrollment): “Further recruitment into the study was ceased on 10th December 2009, not attributed to safety. All patients recruited in the study completed all study visits.”

registry Least Squares Mean Difference 0.41 (90% CI -0.87 to 1.69) NCT00784693 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tanezumab	Monoclonal antibody	15 mg	Intravenous

Indications